| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.35 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |